PA House Health Committee Hearing
Last Updated: Dec 16, 2021
The PA House Health Committee held a public hearing on Monday to hear testimony on COVID-19 treatment options and to discuss the merits of House Bill 1741. HB 1741 would prohibit medical and osteopathic licensing boards from disciplining physicians who prescribe “off-label” medications for the treatment of COVID-19.
The bill would also require pharmacists to fill FDA approved drugs for off-label treatment of COVID-19 without fear of punishment from their licensing board. PAMED will continue to monitor the status of HB 1741.